NEC, Transgene Announce Collaboration In Field Of Individualized Cancer Immunotherapy, Leveraging NEC’s AI And Transgene’s myvac™ Platform
TOKYO, Japan & STRASBOURG, France--(BUSINESS WIRE/AETOSWire)-- NEC Corporation (NEC)(TOKYO:6701) and Transgene (Euronext Paris:TNG) today announced the signing of a Memorandum ...
